Other Industries
Amgen posts top-line results for Remicade alternative in Phase 3 trial
Amgen (AMGN) announced positive top-line results from the phase 3 trial of its biosimilar candidate ABP 710. The drug is…
Rite Aid swings to profit in Q1 on one-time gains
Drugstore chain Rite Aid (RAD) swung to profit in the first quarter owing to one-time gains from the sale of…
It might be the final nail on the coffin for the largest US nail maker
Poplar Bluff, Missouri-based Mid-Continent Nail plant laid off 60 workers last week as steel tariffs affected this household name. By…
HR and payroll services drive Paychex profit higher
Paychex (PAYX) reported a 17% jump in earnings for the fourth quarter, helped by an increase in revenue from HR…
Earnings Preview: Walgreens Boots Alliance
General Electric’s (GE) replacement on the Dow index, drug retail chain Walgreens Boots Alliance (WBA), is said to have a…
Celgene inks a deal with biotech start-up Skyhawk Therapeutics
Biotech start-up firm Skyhawk Therapeutics entered into a five-year deal with Celgene (CELG) in which it will receive an upfront…
Should oil and gas companies be held accountable for global warming?
Climate-change lawsuits filed by the cities of San Francisco and Oakland against five major oil companies were dropped by a…
JinkoSolar stock drops on weak quarterly results
JinkoSolar Holding (JKS) reported a 93.3% dip in earnings for the first quarter due to lower solar module shipments and…
General Electric close to selling the industrial engine unit
The much-delayed sale of General Electric’s (GE) industrial gas engines unit is close to being finalized. Divesting the unit, which…
Incoming Intel CEO has a plate full of problems to solve
Intel Corp. (INTC) is facing a shakeup after the unexpected exit of its CEO Brian Krzanich over non-fraternization policy violations.…